MGMT and glioblastoma: Yoon H.G. et al. examined the predictive performance of machine learning models based on clinical data (age, survival time, sex, ECOG performance status, resection, IDH mutation, MGMT hypermethylation, adjuvant TMZ cycles, total radiotherapy dose) from 118 GBM patients who received radiochemotherapy.